Kenneth Allen Myszkowski, Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 58,332 shares at $54.04 ($3.2M) on 2020-10-20, disclosed to the SEC on 2020-10-22.
Open-market sale of $3.2M ARWR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.04 | 29,166 | $1.6M | 50.0% |
| 2 | $54.04 | 29,166 | $1.6M | 50.0% |
| Total | $54.04 avg | 58,332 | $3.2M | 100% |
| Filing → |
| ARWR | SELL | 2024-01-08 | $885K | — | Filing → |
| ARWR | SELL | 2023-06-29 | $543K | — | Filing → |
| ARWR | SELL | 2022-12-30 | $1.2M | — | Filing → |